About Veritas Genetics
Veritas Genetics is a Healthcare company based in Danvers (United States) founded in 2014 by George M Church, and was acquired by LetsGetChecked in March 2022. Genetic testing products for health risks and traits are offered. Veritas Genetics has raised $53.38 million across 5 funding rounds from investors including LetsGetChecked, Simcere Pharma and Philab. Veritas Genetics has completed 2 acquisitions, including Curoverse and NIMGenetics. Veritas Genetics offers products and services including myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Diversified. Its legal entity is VERITAS GENETICS, INC. Its competitors include 23andMe, Foundation Medicine and GreenLight Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Veritas Genetics was founded in 2014 and is based in Danvers, United States. Genetic testing services in the biotechnology sector are provided by the company. Initial products involve analysis of patient saliva samples for the BRCA gene to evaluate risks of breast and ovarian cancer. The Mygenome test, as the latest offering, enables whole-genome sequencing to identify health conditions and lifestyle traits.
- Headquarters Danvers, United States
- Founders George M Church
- Stage Acquired
- SectorsHealthcare
- Website veritasgenetics.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by LetsGetChecked (Mar 2022)
- Legal Name Veritas Genetics, Inc.
- Total Equity Funding$53.38M (USD)
in 5 rounds
- Latest Funding Round$4.64M (USD), Debt – Conventional
Mar 2018
- InvestorsLetsGetChecked
& 4 more
- Investments & AcquisitionsCuroverse
& 1 more
- Acquired byLetsGetChecked
(Mar 2022)
Products & Services of Veritas Genetics
Veritas Genetics offers a comprehensive portfolio of products and services, including myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk.
Whole genome sequencing for disease prevention and risk analysis
Test for assessing risks of common genetic diseases
Analysis of drug responses based on genetic data
Non-invasive screening for chromosomal abnormalities
Evaluation of hereditary cardiovascular disease risks
Apps and channels of Veritas Genetics
its YouTube channel Veritas Intercontinental has 521 subscribers and 30 videos.
Videos from Veritas Genetics
The most watched videos on Veritas Genetics's YouTube channel, Veritas Intercontinental (521 subscribers). Click a video to play it here.
More on Veritas Intercontinental.
Funding Insights of Veritas Genetics
Veritas Genetics has successfully raised a total of $53.38M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.64 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.38M
- Total Rounds 5
- Last Round Debt – Conventional — $4.64M
- First Round $12M
(Jun 2015)
- Investors Count 4
All 5 funding rounds of Veritas Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $4.64M | Debt – Conventional | – | – | – |
| Feb 2018 | $9.67M | Series B | – | Philab | – |
| Aug 2017 | $1.71M | Series B | – | – | – |
| Oct 2016 | $30M | Series B | – | Trustbridge Partners, Simcere Pharma | |
| Jun 2015 | $12M | Series A | – | – | – |
5 investors in total: 5 institutional.
Investors in Veritas Genetics
Veritas Genetics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include LetsGetChecked, Simcere Pharma and Philab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
early & growth stage tech and life sciences focused VC firm investing primarily in China and the US | trustbridgepartners.com | Shanghai, China | ||
Life science equipment and diagnostic services are provided. | 1959 | philab.com | Taguig, Philippines | |
| lillyasiaventures.com | ||||
Novel oncology and immunology therapeutics are developed and commercialized. | 1995 | simcere.com | Nanjing, China | |
Online platform to order at home diagnostic tests for all health conditions | 2013 | letsgetchecked.com | Dublin, Ireland |
Investor details for Veritas Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Veritas Genetics
2 people are tracked at Veritas Genetics (2 in leadership).
| Name | Role | Group |
|---|---|---|
George M Church | Co-Founder | Leadership |
Matthew Dixon | Chief Business Officer | Leadership |
Complete people profiles for Veritas Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veritas Genetics
Veritas Genetics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Curoverse and NIMGenetics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diagnostic solutions are developed using microarray and next-generation sequencing technologies. | nimgenetics.com | Madrid, Spain | 2007 | Jan 2025 | •••• | |
Genomic and biomedical Big Data infrastructure is provided. | curoverse.com | Boston, United States | 2010 | Aug 2017 | •••• |
Complete acquisition details for Veritas Genetics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Veritas Genetics
6 dated milestones of Veritas Genetics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Veritas Genetics is founded.
- Funding First funding round of $12.0M.
- Acquisition Acquires Curoverse.
- Funding Latest funding round, Debt – Conventional, of $4.6M.
- Exit Acquired by LetsGetChecked.
- Acquisition Acquires NIMGenetics.
Competitors of Veritas Genetics
Veritas Genetics has 3 listed competitors in our database, 3 of them funded. They include 23andMe, Foundation Medicine and GreenLight Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 23andme.com | 2006 | Sunnyvale, United States | $943.53M | 755 | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| greenlightbiosciences.com | 2008 | Lexington, United States | $225.05M | 287 | RNA-based platform for life sciences is developed by GreenLight Biosciences. |
Detailed competitors of Veritas Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Veritas Genetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Veritas Genetics
Complete news archive for Veritas Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veritas Genetics
Veritas Genetics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Veritas Genetics is headquartered in Danvers, United States. It is registered at Danvers, Massachusetts, United States.
Veritas Genetics is a funded company, having raised a total of $53.38M across 5 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Jun 2015.
Veritas Genetics was founded in 2014 and is based in Danvers, United States. Genetic testing services in the biotechnology sector are provided by the company. Initial products involve analysis of patient saliva samples for the BRCA gene to evaluate risks of breast and ovarian cancer. The Mygenome test, as the latest offering, enables whole-genome sequencing to identify health conditions and lifestyle traits.
Veritas Genetics's top competitors include 23andMe, GreenLight Biosciences and Foundation Medicine.
Veritas Genetics offers myGenome, myGeneticRisk, myHealthScore, myPrenatal, and CardioRisk.
Veritas Genetics has made 2 acquisitions, including Curoverse, and NIMGenetics.
Veritas Genetics has 5 investors. Key investors include LetsGetChecked, Simcere Pharma, Philab, Lilly Asia Ventures, and Trustbridge Partners.
Veritas Genetics operates through Veritas Genetics, Inc..
Yes. Veritas Genetics was acquired by LetsGetChecked in March 2022.